• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

犬马拉色菌生物膜的形成。

Biofilm formation of Malassezia pachydermatis from dogs.

机构信息

Dipartimento di Sanità Pubblica e Zootecnia, Università degli Studi di Bari, Str. prov.le per Casamassima Km 3, 70010 Valenzano, Bari, Italy.

出版信息

Vet Microbiol. 2012 Nov 9;160(1-2):126-31. doi: 10.1016/j.vetmic.2012.05.012. Epub 2012 May 18.

DOI:10.1016/j.vetmic.2012.05.012
PMID:22682201
Abstract

Yeasts of the genus Malassezia are commensals of the normal skin microbial flora of humans and animals. These yeasts may become pathogenic under certain circumstances and their pathogenic role may be related to host immune system as well to yeast virulence factors (e.g., phospholipase production and biofilm formation). This study aims to evaluate the in vitro ability of M. pachydermatis strains to produce biofilm, and its relationship with phospholipase activity and the genetic make-up of isolates from lesioned (n=32) and healthy (n=30) dog skin. The production of biofilm was determined by crystal violet staining and scanning electronic microscopy (SEM). Biofilm was produced by almost all M. pachydermatis isolates (95.2%) from dogs with and without skin lesions at variable level and different structure. At the SEM, biofilm matrix presented adhering blastoconidia clustered in multi- or monolayer structures with variable quantity of extracellular production. Of the three genotypes detected, genotype B showed the lowest ability to produce biofilm. Of the 59 isolates producing biofilm, 33 (55.9%) produced phospholipase, with a higher biofilm formation (p<0.05) in strains collected from animals with skin lesions. It is here suggested that phospholipase production might act in synergism with the biofilm formation by inducing or exacerbating skin lesions in dogs. The results provide evidences for a better understanding of the interactions between yeasts and host immune system, toward revealing the pathogenicity of M. pachydermatis in animals.

摘要

厚皮马拉色菌属的酵母是人类和动物正常皮肤微生物菌群的共生体。在某些情况下,这些酵母可能会变得具有致病性,其致病性可能与宿主免疫系统以及酵母毒力因子(例如,磷脂酶的产生和生物膜的形成)有关。本研究旨在评估厚皮马拉色菌菌株在体外产生生物膜的能力,及其与磷脂酶活性的关系,并评估其与来自病变(n=32)和健康(n=30)犬皮肤的分离株的遗传组成的关系。通过结晶紫染色和扫描电子显微镜(SEM)来确定生物膜的产生。来自有和没有皮肤病变的犬的几乎所有厚皮马拉色菌分离株(95.2%)都以不同的水平和不同的结构产生生物膜。在 SEM 下,生物膜基质呈现出附着的芽生孢子聚集在多层或单层结构中,具有不同数量的细胞外产物。在所检测到的三种基因型中,B 型显示出最低的生物膜形成能力。在产生生物膜的 59 株分离株中,有 33 株(55.9%)产生了磷脂酶,并且从有皮肤病变的动物中分离的菌株的生物膜形成能力更高(p<0.05)。因此,可以认为磷脂酶的产生可能通过诱导或加重犬的皮肤病变与生物膜的形成协同作用。这些结果为更好地理解酵母与宿主免疫系统之间的相互作用提供了证据,有助于揭示厚皮马拉色菌在动物中的致病性。

相似文献

1
Biofilm formation of Malassezia pachydermatis from dogs.犬马拉色菌生物膜的形成。
Vet Microbiol. 2012 Nov 9;160(1-2):126-31. doi: 10.1016/j.vetmic.2012.05.012. Epub 2012 May 18.
2
Genetic variability and phospholipase production of Malassezia pachydermatis isolated from dogs with diverse grades of skin lesions.从不同程度皮肤损伤的犬中分离出的厚皮马拉色菌的遗传变异性和磷脂酶产生情况。
Med Mycol. 2010 Sep;48(6):889-92. doi: 10.3109/13693780903532080.
3
Role of beta-endorphin on phospholipase production in Malassezia pachydermatis in dogs: new insights into the pathogenesis of this yeast.β-内啡肽对犬厚皮马拉色菌磷脂酶产生的作用:对这种酵母菌发病机制的新见解
Med Mycol. 2007 Feb;45(1):11-5. doi: 10.1080/13693780600962718.
4
Expression of the micro-opioid receptor on Malassezia pachydermatis and its effect in modulating phospholipase production.马拉色菌属上的μ阿片受体的表达及其对磷脂酶产生的调节作用。
Med Mycol. 2010 Feb;48(1):73-8. doi: 10.3109/13693780902718347.
5
Malassezia pachydermatis from animals: Planktonic and biofilm antifungal susceptibility and its virulence arsenal.动物源马拉色菌:浮游生物和生物膜抗真菌药物敏感性及其毒力武器库。
Vet Microbiol. 2018 Jul;220:47-52. doi: 10.1016/j.vetmic.2018.05.003. Epub 2018 May 4.
6
[Phospholipase and proteinase production by Malassezia pachydermatis isolated in dogs with and without otitis].[从患有和未患中耳炎的犬只中分离出的厚皮马拉色菌产生磷脂酶和蛋白酶的情况]
Rev Iberoam Micol. 2013 Oct-Dec;30(4):235-8. doi: 10.1016/j.riam.2013.01.006. Epub 2013 Feb 18.
7
Correlation between genetic variability and virulence factors in clinical strains of Malassezia pachydermatis of animal origin.动物源厚皮马拉色菌临床菌株的遗传变异性与毒力因子之间的相关性。
New Microbiol. 2016 Jul;39(3):216-223. Epub 2016 Jun 10.
8
Association between phospholipase production by Malassezia pachydermatis and skin lesions.厚皮马拉色菌产生磷脂酶与皮肤病变之间的关联。
J Clin Microbiol. 2004 Oct;42(10):4868-9. doi: 10.1128/JCM.42.10.4868-4869.2004.
9
Biofilm development by clinical isolates of Malassezia pachydermatis.厚皮马拉色菌临床分离株的生物膜形成
Med Mycol. 2007 Jun;45(4):357-61. doi: 10.1080/13693780701225767.
10
Proteinase, phospholipase, hyaluronidase and chondroitin-sulphatase production by Malassezia pachydermatis.厚皮马拉色菌产生蛋白酶、磷脂酶、透明质酸酶和硫酸软骨素酶的情况。
Med Mycol. 2000 Feb;38(1):73-6. doi: 10.1080/mmy.38.1.73.76.

引用本文的文献

1
Production and Quantification of Virulence Factors in Species.物种中毒力因子的产生和定量。
Pol J Microbiol. 2022 Dec 6;71(4):529-538. doi: 10.33073/pjm-2022-047. eCollection 2022 Dec 1.
2
In Vitro Biofilm Formation by Isolates and Its Susceptibility to Azole Antifungals.分离株的体外生物膜形成及其对唑类抗真菌药物的敏感性
J Fungi (Basel). 2022 Nov 15;8(11):1209. doi: 10.3390/jof8111209.
3
In Vitro Assessment of Azole and Amphotericin B Susceptibilities of spp. Isolated from Healthy and Lesioned Skin.从健康皮肤和病变皮肤分离出的**(此处原文 spp. 指代不明,无法准确翻译完整物种名)**物种对唑类和两性霉素B敏感性的体外评估
J Fungi (Basel). 2022 Sep 13;8(9):959. doi: 10.3390/jof8090959.
4
Seleno Containing Compounds as Potent and Selective Antifungal Agents.含硒化合物作为强效和选择性抗真菌剂。
ACS Infect Dis. 2022 Sep 9;8(9):1905-1919. doi: 10.1021/acsinfecdis.2c00250. Epub 2022 Aug 19.
5
Invasive Infection in an 8-Year-Old Child on Lipid Parenteral Nutrition.一名接受脂质肠外营养的8岁儿童发生侵袭性感染。
Case Rep Infect Dis. 2022 Jan 20;2022:8636582. doi: 10.1155/2022/8636582. eCollection 2022.
6
spp. Yeasts of Emerging Concern in Fungemia.引起菌血症的新兴关注酵母菌种。
Front Cell Infect Microbiol. 2020 Jul 28;10:370. doi: 10.3389/fcimb.2020.00370. eCollection 2020.
7
Antifungal Resistance Regarding : Where Are We Now?关于抗真菌耐药性:我们目前的状况如何?
J Fungi (Basel). 2020 Jun 25;6(2):93. doi: 10.3390/jof6020093.
8
Antifungal Therapy: New Advances in the Understanding and Treatment of Mycosis.抗真菌治疗:真菌病认识与治疗的新进展
Front Microbiol. 2017 Jan 23;8:36. doi: 10.3389/fmicb.2017.00036. eCollection 2017.